Literature DB >> 19432825

Costs of neonatal care for low-birthweight babies in English hospitals.

Hema Mistry1, Robin Dowie, Rodney C G Franklin, Bhavdeep R Jani.   

Abstract

AIM: To estimate mean costs of neonatal care for babies with birthweights <or=1800 g in a regional Level 3 unit and three Level 2 units providing short-term intensive care.
METHOD: Babies <or=1800 g admitted to units in four hospitals in England over 15 months in 2001-2002 were audited until discharge. Unit costs (2005-2006 prices) were attributed to their resource items, including neonatal cot occupancy, pharmaceuticals, blood products and ambulance transfers. Bootstrapped mean costs were derived for the Level 3 unit and the Level 2 units combined.
RESULTS: The mean gestation period for 199 Level 3 babies was 29.5 weeks compared with 30.4 weeks for 192 Level 2 babies (p = 0.003). Mean costs excluding ambulance journeys were pound17,861 per Level 3 baby and pound12,344 per Level 2 baby. Level 3 babies <1000 g averaged pound26,815, whereas Level 2 babies <1000 g were generally less costly than babies 1000-1499 g. Ambulances transported 76 Level 3 babies and 62 Level 2 babies; their adjusted mean costs were pound18,495 and pound12,881, respectively.
CONCLUSION: By comprehensively costing resource components, the magnitude of total costs for low-birthweight babies has been revealed, thus demonstrating the importance of budgets for neonatal units being realistically determined by commissioners of neonatal services.

Mesh:

Year:  2009        PMID: 19432825     DOI: 10.1111/j.1651-2227.2009.01316.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix.

Authors:  Edgar Hernandez-Andrade; Roberto Romero; Hyunyoung Ahn; Youssef Hussein; Lami Yeo; Steven J Korzeniewski; Tinnakorn Chaiworapongsa; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2012-03-16

Review 2.  Trends in centralization of very preterm deliveries and neonatal survival in Finland in 1987-2017.

Authors:  Kjell Helenius; Mika Gissler; Liisa Lehtonen
Journal:  Transl Pediatr       Date:  2019-07

3.  Effect of osteopathic manipulative treatment on length of stay in a population of preterm infants: a randomized controlled trial.

Authors:  Francesco Cerritelli; Gianfranco Pizzolorusso; Francesco Ciardelli; Emiliano La Mola; Vincenzo Cozzolino; Cinzia Renzetti; Carmine D'Incecco; Paola Fusilli; Giuseppe Sabatino; Gina Barlafante
Journal:  BMC Pediatr       Date:  2013-04-26       Impact factor: 2.125

Review 4.  Reducing the impact of preterm birth: Preterm birth commissioning in the United Kingdom.

Authors:  Lisa Story; Nigel A B Simpson; Anna L David; Zarko Alfirevic Z; Phillip R Bennett; Matthew Jolly; Andrew H Shennan
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-04-21

5.  The effects of designation and volume of neonatal care on mortality and morbidity outcomes of very preterm infants in England: retrospective population-based cohort study.

Authors:  S I Watson; W Arulampalam; S Petrou; N Marlow; A S Morgan; E S Draper; S Santhakumaran; N Modi
Journal:  BMJ Open       Date:  2014-07-07       Impact factor: 2.692

6.  Birth weight differences between those offered financial voucher incentives for verified smoking cessation and control participants enrolled in the Cessation in Pregnancy Incentives Trial (CPIT), employing an intuitive approach and a Complier Average Causal Effects (CACE) analysis.

Authors:  Alex McConnachie; Caroline Haig; Lesley Sinclair; Linda Bauld; David M Tappin
Journal:  Trials       Date:  2017-07-20       Impact factor: 2.279

7.  Blood pressure change across pregnancy in white British and Pakistani women: analysis of data from the Born in Bradford cohort.

Authors:  Diane Farrar; Gillian Santorelli; Debbie A Lawlor; Derek Tuffnell; Trevor A Sheldon; Jane West; Corrie Macdonald-Wallis
Journal:  Sci Rep       Date:  2019-09-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.